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Myosin light chain kinase
MLCKa b s t r a c t
Mitochondrial ATP synthase, a major ATP supplier in respiring cells, should be regulated in amount
and in activity to respond to the varying demands of cells for ATP. We screened 80 protein kinase
inhibitors and found that HeLa cells treated with four inhibitors exhibited reduced mitochondrial
ATP synthesis activity. Consistently, knockdown of their target kinases (PKA, PKCd, CaMKII and
smMLCK) resulted in a decrease in mitochondrial ATP synthesis activity. Among them, mitochondria
of smMLCK-knockdown cells contained only a small amount of ATP synthase, while the a- and b-
subunits of ATP synthase were produced normally, suggesting that smMLCK affects assembly (or
decay) of ATP synthase.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction The results suggest that smooth muscle type myosin light chain ki-In mammalian cells under aerobic conditions, mitochondrial
ATP synthases (often called FoF1-ATP synthases) produce most of
the cellular ATP in a process driven by a proton motive force, which
is built up by respiratory complexes. The amount and activity of
ATP synthase in cells must be regulated in response to the cells’
changing energy state, but the framework of this regulatory system
is largely unknown. Recently, the involvement of protein kinase in
the regulation of mitochondrial oxidative phosphorylation has
been recognized. One of the subunits of respiratory complex I is
phosphorylated by protein kinase A (PKA) and is recruited to mito-
chondria [1,2]. The d-subunit of ATP synthase is phosphorylated by
platelet-derived growth factor stimulation [3]. In this study, by
adopting a newly developed high-throughput microplate assay
for mitochondrial ATP synthesis [4], we have screened a library
of 80 compounds that have been known to inhibit protein kinases,
and knocked-down the selected inhibitor-target protein kinases.nase (smMLCK) helps to maintain the population of ATP synthase
in mitochondria and hence the ATP synthesis activity. The involve-
ment of PKA, protein kinase Cd, (PKCd), and calcium/calmodulin-
dependent protein kinase 2 (CaMKII) in regulation of ATP synthesis
activity is also indicated.
2. Materials and methods
2.1. Cell culture and materials
HeLa cells were purchased from the Health Science Research
Resources Bank (JCRB9004). They were cultured at 37 C under
5% CO2 in Dulbecco’s modiﬁed Eagle’s medium (Nissui Pharma-
ceutical) supplemented with 10% FBS (Invitrogen) and 1% peni-
cillin/streptomycin. The kinase inhibitor library was obtained
from Enzo Life Sciences International (#2832A). Antibodies
against ATP5A (A21350) and ATP5B (A21351) were purchased
from Molecular Probes; the antibody for the voltage-dependent
anion channel (VDAC) was from Abcam (ab16816); anti-smMLCK
antibody was from SIGMA–ALDRICH (M7905); and anti-PKA
antibody was from Cell Signaling (#4782). The HRP-linked anti-
mouse and anti-rabbit antibodies were from GE Healthcare
(NA931 and NA934). FuGENE HD transfection reagent was from























































Fig. 1. (A) Mitochondrial ATP synthesis activities of HeLa cells treated with
inhibitors of protein kinases. Cells were treated with each of the various inhibitors
for 18 h and mitochondrial ATP synthesis activity was measured by MASC assay.
The rate of ATP synthesis was compared with that of the control cells (treated with
dimethysulfoxide) and only the results of the effective inhibitors are shown (n = 4,
mean ± S.D., ⁄P < 0.05). Oligomycin is a speciﬁc inhibitor of ATP synthase. Targets of
the inhibitors were as follows: staurosporine, pan-speciﬁc; tyrphostin-9, protein-
tyrosine kinase activity of the PDGF receptor; AG-879, protein-tyrosine kinase
activity of the TrkA; GF109203X, hypericin, Ro 31-8220 and sphingosine, protein
kinase C (PKC); H-89, protein kinase A (PKA); KN-93, calcium/calmodulin-depen-
dent protein kinase II (CaMKII); ML-7, myosin light chain kinase (MLCK); 5-
lodotubercidin, mitogen-activated protein kinase, adenosine kinase, casein kinases I
and II, and insulin receptor kinase; Rottlerin, protein kinase Cd (PKCd). (B) Viability
of HeLa cells after an 18 h treatment with the inhibitors (n = 4, mean ± S.D.,
⁄P < 0.05). Details are described in Section 2.
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HeLa cells were passaged on 96-well microplates at 5000 cells/
well and cultivated for 6 h. The culture medium was changed to
Dulbecco’s modiﬁed Eagle’s medium containing an inhibitor (stau-
rosporin at 100 nM and others at 10 lM) and, after an 18 h incuba-
tion, living cells were counted by MTT assay (Cell Counting Kit-8;
Dojindo) and mitochondrial ATP synthesis was measured by MASC
(Mitochondrial Activity of Streptolysin O-permeabilized Cells) as-
say [4]. The MASC assay is a newly developed method for high-
throughput screening of mitochondrial ATP synthesis. Brieﬂy, the
cytoplasmic membranes (but not mitochondrial membranes) of
cells passaged on a 96-well white microplate were permeabilized
by streptolysin O, and their cytosolic components were washed
out. Luciferase, luciferin, 0.1 mM ADP and 5 mM Pi were added
and the reaction was started by addition of 10 mM succinic acid.
When the direct effect of the inhibitors on mitochondria was
examined, the inhibitor was not included in the culture medium
but added at the time of the start of MASC assay (addition of suc-
cinic acid). Luciferin emission was monitored by a luminometer
(Berthold Tech.). After the measurement, cells were washed twice,
the proteins in each well were solubilized by sodium dodecylsul-
fate, and the amount of proteins was measured. The ATP synthesis
rate per unit protein amount was compared. To assess mitochon-
drial membrane potential, HeLa cells were passaged at 7.7  104
cells per 35 mm glass-bottom dish and incubated with the
inhibitors described above. The dishes were set in a microchamber
on a ﬂuorescent microscope at 37 C under 5% CO2 in air, and
tetramethylrhodamine ethylester (TMRE) was added at 50 nM
(ﬁnal concentration). After a 10 min incubation, the potential-
dependent mitochondrial accumulation of TMRE was observed by
ﬂuorescence of TMRE.
2.3. MicroRNA construction and transfection
The microRNA (miRNA or miR) sequences were designed using
an RNAi designer on-line tool (Invitrogen). Two different double-
stranded oligo duplexes encoding the desired miRNA target
sequences for PKCd, a subunit of PKA, a isoform of CaMKII,
and smMLCK were selected and cloned into pcDNA™6.2-GW/
EmGFP-miR expression vector using a BLOCK-iT™ pol II miR RNAi
Expression Vector Kit (Invitrogen). The miRNA target sequences
were as follows: for PKCd_miR-1, 50-CCGCTTCAAGGTTCACAACTA-
30; PKCd_miR-2, 50-TGCCTTCGGAGGGAAATTGTA-30; PKA_miR-1,
50-GCCCACTTGGATCAGTTTGAA-30; PKA_miR-2, 50-TCTTTCCTCCC
AGCAGCGTTT-30; CaMKII_miR-1, 50-AGTATGCTGCCAAGATCATCA-
30; CaMKII_miR-2, 50-AAGGCCCAGTGATCCCATTAT-30; smMLCK_
miR-1, 50-AATGCTGTGAGAGCCATTGGA-30; and smMLCK_miR-2,
50-CTATGTTAGTTGGCACCTTAA-30. The sequence of the negative
control without 50 overhangs was as follows: 50-GAAATGTACTG
CGCGTGGAGACGTTTTGGCCACTGACGTCTCCACGCAGTACATTT-30.
HeLa cells were transfected with miRNAs targeted to PKCd, PKA,
CaMKII or smMLCK using lipofection. After 96 h, ATP synthesis
activities were measured by MASC assay, and cells were collected
for immuno-staining electrophoresis and quantitative PCR.
2.4. Quantitative PCR
The mRNAs for PKCd, CaMKII, and glyceroaldehyde three phos-
phate dehydrogenase (internal calibration control) were quantiﬁed
by PCR. The total RNA was extracted with an Illustra RNAspin Mini
RNA Isolation Kit (GE Healthcare), and cDNAs were synthesized
with PrimeScript II reverse transcriptase using oligo(dT) primer
(TAKARA). PCR was performed on a StepOnePlus™ instrument
(Applied Biosystems) with SYBR Green Master Mix (Applied
Biosystems) using the following primers: for PKCd, forward50-ATGAGCCCCACCTTCTGTGA-30 and reverse 50-TTCTCCCGGCATT-
TATGGTG-30; CaMKII, forward 50-CCTGCATGCACAGACAGGAG-30
and reverse 50-CCTCCGGAGAAGTTCCTGGT-30; and glyceroalde-
hyde three phosphate dehydrogenase, forward 50-GCTCTCCAGAA-
CATCATCCC-30 and reverse 50-TTTCTAGACGGCAGGTCAGG-30. The
mRNA expressions were calculated according to the DDCt method.
2.5. Retroviral gene transduction
An miRNA-expressing retroviral vector was used for stable gene
knockdown. The miRNA target sequences of smMLCK were cloned
into pMX retroviral vector. Retroviruses were prepared and used to
infect the target cells as described previously [4,5].
2.6. Electrophoresis
Clear Native PAGE was performed to analyze the amount of ATP
synthase as described previously [6]. Brieﬂy, whole cells (5 lg pro-
tein) were suspended with solubilization buffer (50 mM NaCl,
50 mM imidazole–HCl, pH 7.0, 2 mM 6-aminohexanoic acid,




























Fig. 2. (A) Mitochondrial membrane potential. HeLa cells treated with the kinase inhibitors for 18 h were incubated with 50 nM TMRE for 10 min and images of TMRE
ﬂuorescence were observed. (B) Effect of kinase inhibitors on ATP synthesis activities of the intact mitochondria. Intact mitochondria were prepared according to the
procedures for MASC assay from HeLa cells that were not exposed to kinase inhibitors. The kinase inhibitor was added at start of the MASC assay (addition of succinate). n = 4,
mean ± S.D., ⁄P < 0.05. Details are described in Section 2.
K. Sugawara et al. / FEBS Letters 587 (2013) 3843–3847 38451 mM EDTA, and 3 mg/ml digitonin) on ice for 10 min. Samples
were centrifuged at 100000g for 15 min at 4 C. The supernatant
was mixed with a loading buffer and applied to electrophoresis at
4 C. SDS–PAGE was performed as described previously [5]. For
immuno-staining, the gel was blotted with PVDF membrane
(Bio-Rad) by a semi-dry blotter (Bio-Rad) at 12 V for 30 min with
Bjerrum buffer supplemented with 20% ethanol and 0.037% sodium
dodecylsulfate. Blotted membranes were stained by mouse
antibodies against the a-subunit (1:20000), b-subunit (1:10000)
of ATP synthase, MLCK (1:5000), PKA (1:10000), or VDAC
(1:40000). The membranes were treated with HRP-linked anti-
mouse IgG antibodies (1:100000) and the bands were visualized
by ECL Advance (GE Healthcare). The chemi-luminescence was de-
tected on a LAS-4000 system (Fujiﬁlm). Staining intensities of the
individual bands were quantiﬁed with ImageJ software (National
Institutes of Health).
3. Results
3.1. Screening of protein kinase inhibitors that affect ATP synthesis
Eighty compounds that have been known to inhibit protein ki-
nases were screened in terms of their effect on mitochondrial ATP
synthesis activity. HeLa cells were exposed to 10 lM of individual
inhibitors (in the case of staurosporin, 100 nM) for 18 h and their
mitochondrial ATP synthesis activities were measured by MASC as-
say. Out of 80 inhibitors tested, mitochondria in the cells treatedwith 12 inhibitors exhibited signiﬁcant decreases in ATP synthesis
activities (Fig. 1A). The decrease in ATP synthesis may have been
caused by cell death, and in fact six inhibitors (staurosporine, GF
109203X, Ro 31-8220, sphingosine, 5-lodotubercidin, rottlerin)
were shown to induce high (>50% of the control cells) cell death
(Fig. 1B). We excluded these six inhibitors from further analysis.
3.2. Direct effect of inhibitors on membrane potential and ATP
synthesis
Mitochondrial ATP synthesis does not occur if the proton mo-
tive force is absent. Therefore, we next examined whether mem-
brane potential, a component of the proton motive force, was
normally generated in cells treated with tyrphostin-9, AG-879,
hypericin, H-89, KN-93, or ML-7. HeLa cells exposed to 10 lM
inhibitors for 18 h were treated with 50 nM TMRE for 10 min,
and then the membrane potential-dependent mitochondrial accu-
mulation of TMRE was observed (Fig. 2A). Mitochondria in the cells
treated with H-89, KN-93 or ML-7 normally generated membrane
potential. Cells treated with tyrphostin-9 or AG-879 exhibited al-
most no accumulation of TMRE in mitochondria. In the case of
hypericin, the localization of TMRE ﬂuorescence was obscured by
the strong red ﬂuorescence of hypericin itself, which spread
throughout the entire cytosolic region (data not shown).
Next, the direct effect of the inhibitors on mitochondrial ATP
synthesis was examined (Fig. 2B). In this experiment, cells were
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Fig. 3. (A) Suppression of the protein levels of PKA and smMLCK in the knockdown
cells. Two kinds of microRNAs (miR-1 and miR-2) were used for knockdown of each
kinase. The cell lysate was analyzed with SDS–PAGE and stained by anti-PKA, anti-
smMLCK or anti-VDAC antibodies. VDAC is an internal control for the amount of
mitochondria. (B) Suppression of the mRNA levels of PKCd and CaMKII in
knockdown cells. The amount of mRNA was assessed by quantitative PCR (n = 3,
mean ± S.D., ⁄P < 0.05). (C) Mitochondrial ATP synthesis activities of the knockdown
cells. Mitochondrial ATP synthesis activities were measured by MASC assay. Details
are described in Section 2.
30μm
control smMLCK-KD1 smMLCK-KD2










































0 5 10 15
Fig. 4. (A) The amount of smMLCK expressed in stable smMLCK-knockdown cells.
Two strains (KD1 and KD2) of permanently knocked-down cells were made using
retrovirus vectors. Cell lysate solubilized by digitonin was subjected to SDS–PAGE
and stained with antibodies to smMLCK, a-subunit, b-subunit and VDAC. (B) The
amount of ATP synthase in stable smMLCK-knockdown cells. The cell lysate
solubilized by digitonin was subjected to Clear Native PAGE analysis and stained
with antibody to b-subunit. VDAC contained in the same samples as analyzed by
SDS–PAGE is shown as an internal control for the amount of mitochondria. (C) Time
course of mitochondrial ATP synthesis of stable smMLCK-knockdown cells
measured by MASC assay (closed symbols). Open symbols indicate the results in
the presence of oligomycin. (D) Stable smMLCK-knockdown cells stained with
TMRE. Details are described in Section 2.
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cytosol components, including protein kinases, should already be
washed from the permeabilized cells (see Section 2) and thus the
direct, instantaneous effect of the inhibitor would be observed.
As a result, two inhibitors, tyrphostin-9 and AG-879, abolished
ATP synthesis activity completely. Together with the results of
Fig. 2A, these ﬁndings led us to conclude that these two inhibitors
acted as an uncoupler and dissipated proton motive force.
Although there was some inhibition, signiﬁcant ATP synthesis
was observed in the presence of hypericin. The other three inhibi-
tors (H-89, KN-93, ML-7) did not interfere with the ATP synthesis
of mitochondria.
3.3. Knockdown of kinases
H-89, KN-93, ML-7 and hypericin are thought to be the inhibi-
tors of PKA, CaMKII, MLCK and PKC, respectively. However, the
speciﬁcity of inhibition is not always very strict and a possibility
of unexpected inhibition was not excluded. To see the contribution
of these protein kinases to ATP synthesis more directly, these ki-
nases were knocked-down by miRNA to suppress their expressions
transiently. In the case of MLCK, it is known that HeLa cells mainly
express two splicing isoforms (200 and 130 kDa) of smoothmuscle-type MLCK (smMLCK) [9], and we knocked-down smMLCK.
PKC has several subfamilies and many isoforms. We generated
knockdown cells of one of the PKC members, PKCd, because its
commitment to ATP synthesis regulation was implicated [10,11].
The efﬁciency of knockdown by two kinds of miRNA for each of
the kinases was assessed by the amount of expressed protein
(Fig. 3A) or mRNA (Fig 3B). Protein levels of smMLCK and PKA were
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was substantially decreased while the level of decrease for both
CaMKII miRNAs was moderate. In accordance with the results for
the inhibitors, mitochondrial ATP-synthesis activities were
decreased signiﬁcantly when any one of the kinases was
knocked-down (Fig. 3C). The extent of the decrease in the activity
was smaller than the extent of the decrease in the expression level.
This can be explained by the fact that mitochondria in HeLa cells
have more than double the amount of the minimum ATP synthase
necessary for the maximum ATP synthesis activity [4]. To
summarize, the suppression of activities of PKCd, PKA, CaMKII
and smMLCK, either by inhibitors or by knockdown, results in
deceleration of ATP synthesis of mitochondria.
3.4. ATP synthase in stable MLCK-knockdown cells
The validity of our screening was veriﬁed by previous reports on
the modulation of mitochondrial ATP synthesis activity by PKCd
and PKA [7,8,10,11]. The other two kinases, CaMKII and smMLCK,
are calcium/calmodulin-dependent kinases. Analysis of CaMKII
will be complicated, because CaMKII includes homo- or hetero-
multimeric forms of the enzymes composed of four different sub-
units, and there are many isoforms that play a variety of roles in
many cellular processes. Therefore, we here focused our study on
smMLCK, which has been implicated in the modulation of muscle
contraction via phosphorylation of the myosin light chain but is
also expressed in non-muscle cells [9]. We established two strains
of stable smMLCK-knockdown HeLa cells using gene transduction
of retrovirus-containing miRNA sequences. Unlike the transient
knockdown by miRNA, the stable knockdown by retrovirus trans-
duction is permanent. Compared with the control cells, stable
smMLCK-knockdown cells expressed reduced amounts of
200 kDa smMLCK (KD1, 4%; KD2, 16%) and 130 kDa smMLCK
(KD1, 4%; KD2, 4%) (Fig. 4A). In the smMLCK-KD cells, the a-
and b-subunit of ATP synthase were expressed normally
(Fig. 4A), but the population of ATP synthase molecules in mito-
chondria analyzed with Clear Native PAGE was signiﬁcantly de-
creased, that is, 47% (KD1) and 60% (KD2) of the control cells
(Fig. 4B). The excess amounts of a- and b-subunit that were not
incorporated into ATP synthase were probably missed during the
procedures of Clear Native PAGE. As expected from the decreased
population of ATP synthase, mitochondria in smMLCK-knockdown
cells synthesized ATP at a slow rate, 70% of the control cells
(Fig. 4C). The morphology and membrane potential of mitochon-
dria were not damaged by the knockdown (Fig. 4B). From these re-
sults, we conclude that smMLCK contributes to maintenance of the
population of mitochondrial ATP synthase.
4. Discussion
Using new screening methods for mitochondrial ATP synthesis
activity, we identiﬁed four protein kinases (PKA, PKCd, CaMKII
and smMLCK) that contribute to the regulation of mitochondrial
ATP synthesis activity. In support of our approach, independent
studies have revealed involvement of PKA and PKCd in the regula-
tion of mitochondrial ATP synthesis [7,8,10,11]. PKA inactivates the
ﬁssion-facilitator protein Drp1 by phosphorylation, leading to
elongation of mitochondria and maintenance of ATP level duringstarvation. PKCd interacts directly with, but probably does not
phosphorylate, the d-subunit of ATP synthase. In the case of the
other two protein kinases, CaMKII and MLCK, there have been no
previous reports suggesting that they are involved in regulation
of mitochondrial ATP synthesis. These two kinases are not included
in the list of mitochondrially located proteins [12] and therefore
they phosphorylate proteins in the cytosol that are bound for or
interact with mitochondria. We also found that suppression of
smMLCK results in a decreased population of ATP synthase. This
might be a result of an imbalance in the assembly/degradation of
ATP synthase, but probably does not arise through the biosynthesis
of subunit proteins (Fig. 3A). Further studies will be needed to
identify the mechanism by which smMLCK regulates the popula-
tion of mitochondrial ATP synthase.
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